A high-throughput panel for identifying clinically relevant mutation profiles in melanoma.
Dutton-Regester K, Irwin D, Hunt P, Aoude LG, Tembe V, Pupo GM, Lanagan C, Carter CD, O'Connor L, O'Rourke M, Scolyer RA, Mann GJ, Schmidt CW, Herington A, Hayward NK.
Dutton-Regester K, et al.
Mol Cancer Ther. 2012 Apr;11(4):888-97. doi: 10.1158/1535-7163.MCT-11-0676. Epub 2012 Mar 1.
Mol Cancer Ther. 2012.
PMID: 22383533